Lncrna Glelr Modulates Microglia Inflammatory Programs In Association With PU.1
Our brains contain specialized immune cells called microglia, which play a crucial role in maintaining brain health. However, when these cells become overly active or “inflamed,” they can contribute to neurodegenerative diseases like Alzheimer’s. Recent research has shed light on a fascinating new player in this process: a type of genetic material known as a long non-coding RNA, or lncRNA. Unlike traditional genes that provide instructions for making proteins, lncRNAs don’t directly produce proteins but instead act as important regulators of other genes.
Scientists have discovered an lncRNA, found in both mice (named Glelr) and humans (named ENSG00000272070), that appears to be a critical modulator of microglial activity. This lncRNA becomes more abundant as we age. The study found that this lncRNA works by interacting with a specific protein called PU.1, which is a “transcription factor.” Transcription factors are like master switches that turn genes on or off, thereby controlling various cellular processes. In this case, PU.1 is a key controller of how microglia behave.
When the researchers reduced the levels of this lncRNA, they observed that microglia became more pro-inflammatory, meaning they produced more inflammatory signals (like cytokines) and increased their “phagocytic activity,” which is their ability to engulf and clear cellular debris. This suggests that the lncRNA normally helps to keep microglial inflammation in check.
Intriguingly, the human version of this lncRNA, ENSG00000272070, was found to be significantly reduced in the brains of individuals with Alzheimer’s disease. Furthermore, many genes associated with Alzheimer’s were also influenced by this lncRNA. These findings suggest that this lncRNA could be a crucial link between aging, microglial inflammation, and the development of Alzheimer’s disease. Understanding how this lncRNA-PU.1 interaction works could open new avenues for developing therapies to fine-tune microglial activity and potentially combat neuroinflammation in diseases like Alzheimer’s.
Source: link to paper